Clinical trial
Randomised, Double-blind, Placebo-controlled, Dose-escalation Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke
NCT01104467 is registered in ClinicalTrials.gov with Lundbeck Japan K. K. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised, Double-blind, Placebo-controlled, Dose-escalation Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke
- Lead sponsor
- Lundbeck Japan K. K.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- August 31, 2013
- Enrollment
- 48 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke